Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma
Abroad (travel likely)RecruitingPHASE2
Conditions
Adenocarcinoma of Small Intestine · Appendix Carcinoma · Metastatic
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Study leads
Yanhong Deng, Ph.D
Principal Investigator
Sixth Affiliated Hospital, Sun Yat-sen University